Sign In
Buy LLY
$1,185.71
-6.23 (-0.523%)
At Close: Aug 07, 2026
Why Eli Lilly Stock Crawled Higher Today
06:24pm, Monday, 09'th Oct 2023
According to the results of a recent survey, inclusion of weight-loss drugs is set to ramp up dramatically. More than a few businesses plan to include such coverage in their healthcare insurance polic
Cramer says Vertex has a drug that may address the 'largest market opportunity in the world'
10:18am, Monday, 09'th Oct 2023
CNBC's Jim Cramer said investors keep an eye on Vertex Pharmaceuticals (VRTX) as the company develops a non-opioid pain drug.
Eli Lilly, McKesson, Novartis Flash Promising Chart Action
07:19am, Monday, 09'th Oct 2023
Although healthcare stocks lag other sectors, large-cap leaders such as Eli Lilly & Co. NYSE: LLY, McKesson Corp. NYSE: MCK and Novartis AG NYSE: NVS are in possible buy ranges as they get moving-
Rate Watching And Why The Bond Market Matters
04:00pm, Sunday, 08'th Oct 2023
The bond market and interest rates were the biggest news items of the week. The absolute level of the 10-year bond rate is causing havoc in various sectors, such as housing and commercial real estate.
3 Biotech Stocks Ready to Break Out in 2024
09:00am, Saturday, 07'th Oct 2023
While the S&P 500 remains up on the year, the biotech sector is down. Even though the broader market is showing signs of strength in areas like AI and automation, those trends haven't benefited biotec
3 No-Brainer Growth Stocks to Buy in October
06:53am, Saturday, 07'th Oct 2023
Eli Lilly is crushing the market because of its impressive product lineup and strong prospects. Novo Nordisk is just getting warmed up with a massive opportunity for Ozempic and Wegovy.
Eli Lilly pipeline of obesity treatments is positioned to pay off beyond just Mounjaro, analysts say
03:01pm, Friday, 06'th Oct 2023
Shares of Eli Lilly and Co (NYSE:LLY) rose Friday after analysts at Bank of America reaffirmed its confidence in the company. The firm reiterated its Buy rating and upped its price target to $700 from
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
10:31am, Friday, 06'th Oct 2023
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
2 Reasons Why Eli Lilly's Mounjaro Might Beat Novo Nordisk's Ozempic, and 2 Reasons Why It Might Not
08:15am, Friday, 06'th Oct 2023
Ozempic and Mounjaro are key drugs for Novo Nordisk and Eli Lilly, respectively. Both treat most of the same conditions, and both are major drivers of earnings.
Should You Sell This Stock After Another Regulatory Headwind?
06:09am, Friday, 06'th Oct 2023
Eli Lilly set out to launch four new products this year, but it is unlikely to do so. The company's regulatory roadblocks aren't deal-breakers for its medicines.
What Are The Best Stocks To Invest In? 2 Healthcare Stocks To Know
10:38am, Thursday, 05'th Oct 2023
Healthcare stocks to watch right now.
Here's the Best Big Pharma Stock of the Decade so Far (and It's Not Even Close)
05:50am, Thursday, 05'th Oct 2023
There have been relatively few big winners among pharma stocks so far in the 2020s. One big pharma stock stands out as the clear leader by roughly tripling over the last nearly four years.
Eli Lilly (LLY) Surpasses Market Returns: Some Facts Worth Knowing
06:47pm, Wednesday, 04'th Oct 2023
Eli Lilly (LLY) concluded the recent trading session at $531.46, signifying a +1.19% move from its prior day's close.
Lilly (LLY) to Buy POINT Biopharma, Strengthen Cancer Portfolio
09:46am, Wednesday, 04'th Oct 2023
Eli Lilly's (LLY) acquisition of POINT Biopharma, if successfully closed, is likely to bolster its portfolio of cancer drugs.
Eli Lilly exec behind diabetes blockbuster set retire
08:34am, Wednesday, 04'th Oct 2023
Mike Mason, the executive vice president and president of Lilly Diabetes & Obesity at Eli Lilly and Co (NYSE:LLY), is set to retire at the end of this year after a 34-year tenure with the pharmaceutic
